To kick things off, we'll set the stage on what defines non-muscle invasive bladder cancer and how we triage patient ...

In July 2025, the FDA granted priority review for TAR-200 as therapy for patients with high-risk nonmuscle invasive bladder ...

The JAVELIN Bladder 100 trial established avelumab (Bavencio) as a standard switch maintenance therapy, according to Grivas. It showed significant survival benefit for patients who achieve disease ...

Adjuvant radiotherapy could substantially reduce risk for locoregional recurrence for patients with advanced muscle-invasive ...

In a recent conversation with CURE, Hensley discussed the current treatment landscape of non-muscle-invasive bladder cancer, as well as how patient counseling is guided by individual risk factors.

For the first time, a device for releasing local chemotherapy in the bladder has been approved in the U.S., for patients who do not respond to standard treatment.

Deion Sanders provided an update on his health after his bladder cancer treatment, stating that he thinks he has gotten “more ...

Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, ...

Bladder cancer patients who run out of options often face a grim choice: life-altering surgery to remove the bladder, or living with a disease that might kill them if it spreads to the rest of the ...

The 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting held in San Francisco, CA between September 28 th and 30 th, 2025, was host to a bladder and post-prostatectomy radiation ...

Bladder cancer is one of the most common cancers worldwide. Men are around four times more likely to develop it than women, ...

I’m not getting blood to my leg. That’s why my leg is throbbing,” said the Colorado Buffaloes coach, who recently had his ...